LEUKEMIA
Clinical trials for LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA trials appear
Sign up with your email to follow new studies for LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized stem cell transplant aims to beat inherited blood cancers
Disease control Not yet recruitingThis study tests a stem cell transplant tailored to each person with blood cancer caused by a RUNX1 gene mutation. About 98 participants aged 4 to 70 will receive chemotherapy and transplant, with medication doses adjusted individually. The goal is to see if this personalized app…
Matched conditions: LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for tough blood cancers: BT02 drug trial launches
Disease control Not yet recruitingThis study tests a new drug called BT02 in people with blood cancers (leukemia, lymphoma, or multiple myeloma) that have returned or not improved with standard treatments. About 116 adults aged 18 to 70 will receive the drug by IV every 2-3 weeks for up to 2 years. The main goals…
Matched conditions: LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Biotroy Therapeutics • Aim: Disease control
Last updated May 13, 2026 16:04 UTC
-
New hope for tough leukemia: Triple-Drug attack trial launches
Disease control Not yet recruitingThis early-phase study tests whether adding a new drug called eganelisib to two standard AML treatments (venetoclax and azacitidine) is safe and helps control the disease. It enrolls 48 adults with AML that has returned or not responded to prior therapy. The main goal is to find …
Matched conditions: LEUKEMIA
Phase: PHASE1 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Promising new combo therapy aims to boost survival in young leukemia patients
Disease control Not yet recruitingThis study tests a chemotherapy regimen that includes the immunotherapy drug blinatumomab for adolescents and young adults (ages 15-39) with newly diagnosed Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL). The goal is to see if this treatment plan helps more p…
Matched conditions: LEUKEMIA
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
New study aims to tackle weight gain in kids cured of leukemia
Disease control Not yet recruitingThis study compares two weight management programs for children who have had acute lymphoblastic leukemia (ALL) and their caregivers. One program provides basic educational materials, while the other offers a more guided family-based approach. The goal is to help these children m…
Matched conditions: LEUKEMIA
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 05, 2026 11:55 UTC
-
New study aims to improve Long-Term health tracking for childhood cancer survivors
Knowledge-focused Not yet recruitingThis study will follow 400 children and teens who have survived blood cancers like leukemia and lymphoma. Researchers want to understand the long-term health problems these survivors face and create a structured follow-up plan using an electronic platform. The goal is to improve …
Matched conditions: LEUKEMIA
Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Knowledge-focused
Last updated May 17, 2026 00:51 UTC
-
Exercise may turn back the clock for blood cancer survivors
Knowledge-focused Not yet recruitingThis study looks at whether a special exercise program can help older adults who have survived blood cancers like leukemia or lymphoma age more slowly. Researchers want to find out how much and what type of exercise works best. About 180 people aged 50 and older will take part, a…
Matched conditions: LEUKEMIA
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC
-
5,000 patients to help unravel Immune-Blood link
Knowledge-focused Not yet recruitingThis study will follow 5,000 adults with immune system issues to see how often they also have clonal hematopoiesis (a type of blood cell change) or related blood diseases like VEXAS syndrome. Researchers will track new cases over time to better understand these conditions. No tre…
Matched conditions: LEUKEMIA
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 04, 2026 16:23 UTC